Ottobock shares are still falling behind: further growth is expected to follow the increase in sales and profits

The prosthesis manufacturer Ottobock increased sales and profits significantly last year. The company benefited from new products and acquisitions. Ottobock was optimistic for further growth in 2026. However, some analysts and investors on the stock market had expected a little more. The share price came under pressure.

“We are very satisfied with the results we achieved in the 2025 financial year. As in previous years, we have further expanded our position as market leader with double-digit organic growth rates and achieved a jump in profitability,” explained CEO Oliver Jakobi on Tuesday when presenting the preliminary figures in Duderstadt near Göttingen.

The group is best known for its prostheses and technical support for the Paralympics. According to its own information, the company is the world market leader in the field of prosthetics. Ottobock only went public last October and was promoted to the SDAX small-cap index in December.

In the last financial year, sales rose by a total of 4.7 percent to almost 1.7 billion euros, as the company reported. In the core business, the increase was 11.7 percent. Adjusted earnings before interest, taxes, depreciation and amortization (Ebitda) in the core business increased by almost 30 percent to 415.3 million euros. The corresponding margin improved by 3.6 percentage points to 26 percent. While operating profit development was better than analysts had previously expected, consolidated sales were slightly below consensus estimates.

The core business at Ottobock includes the Products & Components and Patient Care divisions. Ottobock has classified areas that have been sold or are to be sold as “non-core business”.

Ottobock brought numerous new products onto the market last year, such as the next generation of a knee joint for highly active users and a completely revised product generation in arm and hand prosthetics, the company explained the development last year.

In 2026, revenues in the core business are expected to increase by five to eight percent; However, some experts have so far had a little more on their agenda. The adjusted margin (Ebitda) in the core business should be more than 26.5 percent. Ottobock confirmed the medium-term forecasts up to 2029 with organic growth of seven to nine percent and a further improvement in the adjusted Ebitda margin in the core business to 29 to 30 percent.

This is how the Ottobock share moves

Ottobock shares came under pressure on Tuesday after the publication of business figures.

In XETRA trading, the Ottobock share was temporarily 2.85 percent lower at 56.20 euros.

The record low of 54.85 euros from the previous week is getting closer again. Since the IPO in October 2025 at an issue price of 66 euros, the shares have now lost around 15 percent.

Although experts generally praised the results, analyst Richard Felton from Goldman Sachs was bothered by the sales outlook for 2026. It is slightly below expectations and the growth rate the company is aiming for in the medium term.

The analyst considers the target to be reasonable and conservative, but in conjunction with the sluggish fourth quarter it could lead to corrections to the consensus.

/nas/mis

DUDERSTADT (dpa-AFX)

Selected leverage products on Ottobock

With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Ottobock

The leverage must be between 2 and 20

Advertising